000 01260 a2200385 4500
005 20250513222635.0
264 0 _c20010125
008 200101s 0 0 eng d
022 _a0315-162X
040 _aNLM
_beng
_cNLM
100 1 _aGaubitz, M
245 0 0 _aCerebral aspergillosis in systemic lupus erythematosus.
_h[electronic resource]
260 _bThe Journal of rheumatology
_cOct 2000
300 _a2518-9 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAmphotericin B
_xtherapeutic use
650 0 4 _aAntifungal Agents
_xtherapeutic use
650 0 4 _aBrain
_xmicrobiology
650 0 4 _aCyclophosphamide
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunocompromised Host
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aItraconazole
_xtherapeutic use
650 0 4 _aLiposomes
650 0 4 _aLupus Erythematosus, Systemic
_xcomplications
650 0 4 _aNeuroaspergillosis
_xdiagnostic imaging
650 0 4 _aTomography, X-Ray Computed
700 1 _aMoskopp, D
700 1 _aFegeler, W
700 1 _aHilker, E
700 1 _aDomschke, W
773 0 _tThe Journal of rheumatology
_gvol. 27
_gno. 10
_gp. 2518-9
999 _c10981907
_d10981907